The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...

On January 8, 2026, Collegium Pharmaceutical, Inc. issued full-year 2026 guidance, projecting US$805 million to US$825 million in net product revenues and highlighting new authorized generic supply ...

Major domestic pharma companies are witnessing pricing pressure in the generics segment in the US, their largest export market. Many of them are trying to address this by focusing more on high-value ...

The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

The Trump administration's approval of generic abortion pills has prompted an immediate and strong condemnation from conservative lawmakers who question the safety of the pill, given the timeline of ...

At times, a Windows user may encounter problems while connecting to an external monitor. They may either see an error message that says, “Failed to load hardware ...

Dr. Reddy’s Laboratories (NYSE:RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo Nordisk’s (NVO) weight loss drug Wegovy, in 87 countries beginning in 2026, ...

We are still reporting. If you are a current or former FDA employee or someone in the industry with information about the agency, the safety of generic drugs, or the manufacturers that make them, our ...